Neumann Clarke

Avg. Two Year Performance

19% Avg. Purchase Return
9% Compound
47% Avg. Sale Return
21% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return24%97%271%153%19%
Purchase Success Rate2 of 22 of 22 of 22 of 21 of 2
Average Sale Return(3%)7%30%40%47%
Sale Success Rate2 of 42 of 44 of 44 of 44 of 4

Sequenom Inc.

Drugs » Biotechnology

VP & General Counsel:

Holdings: 21.91K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Biora Therapeutics, Inc.

Other » Other

See Remarks:

Holdings: 492.19K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--